EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H28N8O2 |
| Net Charge | 0 |
| Average Mass | 460.542 |
| Monoisotopic Mass | 460.23352 |
| SMILES | N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)nncc3n2)CC1 |
| InChI | InChI=1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29) |
| InChIKey | NLFLXLJXEIUQDL-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gusacitinib (CHEBI:757778) has role antineoplastic agent (CHEBI:35610) |
| gusacitinib (CHEBI:757778) has role dermatologic drug (CHEBI:50177) |
| gusacitinib (CHEBI:757778) is a piperidines (CHEBI:26151) |
| INN | Source |
|---|---|
| gusacitinib | WHO MedNet |
| Synonyms | Source |
|---|---|
| ASN-002 | ChEMBL |
| ASN002 | ChEMBL |
| EN-3351 | ChEMBL |
| EN3351 | ChEMBL |
| Citations |
|---|